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Abstract
One of the challenges for ‘post-genomic’ biology is the integration of data from many different
sources. Two recent studies independently take steps towards this goal for Escherichia coli, using
mathematical modeling and a combination of gene expression and protein levels to predict new
gene functions and metabolic behaviors. 
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It has become a platitude of the post-genomic era that a
deluge of data is being produced and awaits both computa-
tional/mathematical analysis and experimental verification.
There is no reason to argue with this observation, yet it
leads to two immediate follow-up questions. First, has the
genomic era come to an end already? And second, what
types of mathematical and computational models would be
most beneficial for dealing with the rich streams of data?
Two recent articles, by Reed et al. [1] and Corbin et al. [2],
answer the first question in the negative: there is still a lot
of genomic research to be done. These two articles show
that, even for one of the best studied of organisms,
Escherichia coli, there are still very many genes for which
we know little beyond their sequence and location. We don’t
know what their functions are, exactly which genes are
actively functioning at any one time, and to what degree
some might even be entirely dispensable. The experimental
approach proposed by Corbin et al. [2] sheds light on
some of these issues with a combination of two methods,
one for measuring gene expression and one for detecting
proteins in E. coli cells. In contrast, Reed et al. [1] address
the two questions with a novel and interesting application
of mathematical modeling.
The combination of the two papers is intriguing, because both
have the same purpose - annotating gene function and learning
more about intermediary metabolism - yet the two use very
different approaches to accomplish their common goal. This
independence of approaches may be useful for comparisons
or for mutual complementation of results, and could aid the
community in answering questions about the reliability of
separate approaches to interpreting genomic information. 
To assign metabolic functions to unknown genes, Reed et al.
[1] use a method that is based on a combination of mathe-
matical modeling and data mining. The authors use the
available literature and database information to construct a
large stoichiometric model of intermediary metabolism that
includes all known biochemical reactions in E. coli. A stoi-
chiometric model describes quantitatively the flow of mass
through a metabolic network. It includes one linear differen-
tial equation for each metabolite, and each of these equa-
tions consists of the sum of all fluxes leading to the
production of this metabolite minus the sum of all fluxes
degrading or consuming this metabolite. To determine the
sizes of all internal fluxes, one measures some input and
output fluxes, such as substrate uptake and lactate or carbon
dioxide excretion. Under the assumption that all reactions
are in a dynamic steady state, the fluxes at each metabolite
should be numerically balanced. Typically there is not
enough input-output information to compute all internal
fluxes, but the stoichiometry severely constrains the range of
possibilities, and optimization within this range leads to the
desired internal flux distribution (reviewed in [3,4]). Although the assumption of flux balance is found to be true
in the majority of cases, the authors detect notable excep-
tions and conclude that some catalytic steps must be missing
from the model structure [1]. Analysis of metabolic maps in
other organisms suggests mechanisms (enzymes and cat-
alyzed reactions) associated with the depletion of those
metabolites that accumulate in the current model, or the
production of metabolites that are not made available in suf-
ficient quantities in the model. In many cases, these mecha-
nisms have been characterized in other organisms, and often
their genes and gene sequences have been determined. This
information is used to search for similar sequences among
unknown E. coli genes and thus leads to proposals for new
annotations for formerly unidentified open reading frames
(ORFs). Thus, through the integration of metabolic data by
means of a mathematical model, inconsistencies in the
model lead to new discoveries, or at least to suggestions for
targeted experiments that would confirm or reject the
hypothesized annotation.
The metabolites reported by the current model as accumu-
lating without removal are called ‘dead-end’ metabolites [1].
The list is interesting from a biochemical point of view,
because it consists of a mixture of types of compounds. Some
of the metabolites are common, essential compounds whose
balances must be managed by the cell, such as thymine and
siroheme. The apparent accumulation of these compounds
by the model may point to incomplete biochemical data.
Data of this sort should be useful for finding omissions in the
model and for the annotation of genes. Some of the other
metabolites on the list are approaching the macromolecule
category. All reactions associated with these metabolites
would, therefore, not be expected to be present in any model
of small-molecule metabolism. Examples of these are ‘cold-
adapted KDO2 lipid A’ and a ‘peptidoglycan subunit’. Other
entries in the dead-end list may be eccentric names for
normal metabolites: for example, T-trans-aconitate instead
of the usual trans-aconitate, and D-D-Methionine instead of
either D-methionine or L-methionine. 
To assign functions to particular genes, possible connections
between ‘missing functions’ (enzymes and their reactions)
and particular E. coli gene sequences are deduced by
sequence similarity searches. This data-mining and annota-
tion step apparently used older information about E. coli
gene products and for this reason, one finds many of the pre-
dictions cogent because they exist in the current databases.
The authors list putative genes for nearly 30 functions (see
the Additional data files of [1]). We compared the predic-
tions with information in a current database [5] and found
that many of the predictions verify the approach taken
because they are essentially the same as the currently
‘known’ or ‘putative’ assignments. A few of the predictions
seem unlikely given the functions of sequence-similar pro-
teins. Some of the predictions, however, are indeed new con-
nections to uncharacterized genes that could now serve to
motivate experimental verification. On the whole, the
approach to annotation through metabolic circuitry seems to
have the capability in the future of expanding metabolic
and/or genetic knowledge and directing the experimental
verification of new functions. 
Entirely different approaches are used by Corbin et al. [2] to
characterize both protein and mRNA populations in E. coli
cultures. Proteins extracted from growing cells are visualized
using high-pressure liquid chromatography combined with
tandem mass spectrometry (HPLC-MS/MS). Over 1,100
ORFs were detected, corresponding to a quarter of all possi-
ble gene products. It is not known what fraction of E. coli pro-
teins is present in detectable amounts under the growth
conditions used, but one can safely expect that not all genes
are expressed at any one time; to detect more than a quarter
of all gene products is therefore an impressive feat. Compar-
ing these protein results with mRNA levels, measured sepa-
rately by hybridization to an Affymetrix chip, the authors find
a good correlation between the two types of measurements,
provided that the intensity of the mRNA signal does not fall
within the lowest 5% of the measured range. For lower inten-
sities, the correspondence to detected proteins is no longer
significant, an observation that might be attributable to the
fact that reliable detection of the proteins by HPLC-MS/MS
requires relatively high levels of expression [2].
The two-pronged approach of assessing proteins that are
directly involved in metabolic function versus mRNAs that
are only involved indirectly raises the question of whether
we can actually learn anything from the mRNA results that
we did not already know. The answer is that there is indeed
added value. Identification of the collection of expressed
genes in E. coli [2] allows us to ask whether the list corre-
sponds to our a priori expectations of which catabolic, ana-
bolic and macromolecular-synthesis proteins are made
under the specific growth conditions. Using a relatively per-
missive threshold one finds that about 27% of the 955 known
metabolic enzymes in the mRNA experiments are not
expressed during growth on glycerol as a carbon source. This
is not a surprise, because we know that many enzymes are
made only in response to particular growth conditions.
(Note that the computational model of Reed et al. [1] uses a
collection of 927 entities, of which 733 are enzymes and the
rest are transporters. All are presumed to be active members
of the metabolic network in the computational model [1],
although the experimental data of Corbin et al. [2] suggest
that many are repressed).
The data from the mRNA experiments reveal both previ-
ously known and unknown unexpressed genes. The known
interruption of the gatR repressor gene in E. coli strain
MG1655 is confirmed as the galactitol genes are derepressed
as expected [2,6]. The mRNA levels of the sorbitol and
mannitol degradation enzymes are derepressed [2], suggesting
that the GatR repressor is involved in the regulation of these
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gene, was not known to the authors, but it was flagged by a
derepressed mRNA signal [2]. The defect in pyrE was later
confirmed by growth-rate studies [5]. Thus, unknown genes
are readily detected experimentally.
Rich information may be extracted from the data on which
isozymes are metabolically active in the selected medium.
Although Corbin et al. [2] did not present detailed functional
analysis of gene expression, data of this kind can be
extracted. For instance, inspection of the data shows that
shikimate kinase I is expressed more than shikimate kinase
II, two of the five peptidylprolyl isomerases are most highly
expressed, and three of the four FK506/rapamycin-binding
protein-type peptidylprolyl isomerases are most highly
expressed. Two 3-oxo(acyl carrier protein)synthases, I and
III, are well expressed, but very little of isozyme II is present.
Numerous other insights of this type can be deduced directly
from the data.
An observation brought out by Corbin et al. [2] is that genes
in operons are not always coordinately expressed, because in
many cases only some, not all, members of an operon were
detected as present at the protein level (for a similar obser-
vation see [7]). This leads to the following deduction. As
enzyme activity is not a direct function of the amount of
mRNA present - because mRNA half lives can differ, transla-
tion efficiencies can differ, and specific activities of enzymes
range widely - the amount of active mRNA may be regulated
so as to produce similar enzyme activities. If true, this con-
clusion from the data of Corbin et al. [2] opens avenues of
potentially fruitful investigation.
Another direct value of the experimental results is, of course,
that the identification and quantification of proteins and
mRNAs in the cell under particular growth conditions
provide valuable in vivo input for computational pathway
models. Furthermore, the results can be used for validation
purposes, where comparisons are made between the list of
proteins found experimentally and the pathways and fluxes
included in a computational model. 
Returning to the questions posed at the beginning of this
article, one may ask whether the computational modeling
procedure [1] falls into the realm of genomic or post-
genomic research. This may sound like a purely academic
question, but it leads us to ask what is needed next in terms
of computational and mathematical analysis. Even though
the model of Reed et al. [1] is integrative, one would proba-
bly assign the particular use presented here to the genomic
era, because the model serves as a data collection and gene-
identification tool. It helps classify data in a novel fashion
by using metabolite anomalies to identify possible missing
reactions and enzymes, and suggests novel connections
between missing enzymes and their genes through
sequence analysis. This is an intriguing role for modeling,
and the approach constitutes a fine example of practical
model utilization. 
Is the model useful beyond this role? In the work of Reed et
al. [1] and the related literature [3,4] it is claimed that a large
stoichiometric model describes metabolism with sufficient
reliability to make predictions of organismal responses under
untested conditions and to serve as a basis for optimizing
E. coli strains for particular tasks of biotechnological interest.
Indeed, examples have been presented where such predic-
tions were successful [8]. Nevertheless, it must be recognized
that the mathematical structure of any purely stoichiometric
model precludes a true inclusion of kinetic and regulatory
features. Under novel conditions, the cell is likely to respond
by calling up its regulatory-control mechanisms, but this
cannot be modeled with stoichiometry alone, except that once
all regulation is done, the metabolic network should again
reside at a steady state, in which all metabolites are balanced. 
The question then becomes whether a constrained linear
optimization of a stoichiometric model would actually reach
the same balanced state that the real cell would assume
through its regulatory mechanisms. At this point, this ques-
tion cannot be answered with any generality, except that
there will almost certainly be cases where the linear predic-
tion is correct but there will also be cases where that is not
so. For instance, the cell may ‘decide’ to export unwanted
metabolites, or it may resort to pathways that are mini-
mized under normal conditions and used only under spe-
cific conditions. As an example, it would seem difficult to
predict with a stoichiometric model alone that a yeast cell
would respond to heat shock with an enormous production
of trehalose, which exists only in traces under cooler condi-
tions. Thus, there need to be additional phases of model
development and analysis on the path towards understand-
ing organismal function. 
The most obvious extension beyond stoichiometric models is
the construction of nonlinear models, which can account for
regulatory features (see, for example, [9]). These clearly
require much more input in terms of pathway information
and kinetic and regulation data but will have an improved
chance of adequately representing tested and untested
organismal behaviors. Like stoichiometric models, however,
nonlinear models will eventually also encounter the ‘curse of
combinatorial explosion’. Once these models reach a certain
size, it becomes an overwhelming task to implement them
numerically, to test the reliability of explicit and implicit
assumptions associated with the model set-up, and to inter-
pret the results. For instance, if a model contains ten para-
meters with ten possible values each, and if each model
analysis takes one second, an exhaustive evaluation would
require 317 years of computation time. Obviously, clever
coding, parallelization and other advancements will reduce
this time, but it is nevertheless quite obvious that such an
approach is bound to break down eventually.
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eling and simulation is the discovery of general principles
that govern the behavior of organisms and their responses to
stimuli [10]. Such principles provide an objective rationale
for a particular design and operation of a gene-regulatory,
metabolic or physiological system and will ultimately allow
us to dissect large systems into interacting functional
modules. They will also give us confidence in predicting
responses under novel conditions, optimizing strains, or
ultimately designing new strains from scratch. Both exten-
sions, toward nonlinearities and toward the exploration of
design and operating principles, will require solid and
detailed information on the components of biological
systems. The two papers discussed here [1,2] provide some
such information and are therefore important in that they
help us, in independent ways, to make the current ‘parts
catalog’ of E. coli more complete, precise and reflective of
the contents of the cell in specified conditions.
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